SciSparc Receives Nasdaq Non-Compliance Notice for Minimum Stockholders' Equity
summarizeResumen
SciSparc Ltd. has received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement, reporting a negative equity balance of approximately $(81,000) as of June 30, 2025, significantly below the $2.5 million threshold. This notice highlights severe financial distress and poses a material risk to the company's Nasdaq listing if not resolved. While the company expects to regain compliance by December 31, 2025, through recent financing activities, investors should closely monitor the situation as failure to meet Nasdaq's requirements could lead to delisting.
check_boxEventos clave
-
Nasdaq Non-Compliance Notification
SciSparc Ltd. received a notification from Nasdaq for failing to meet the minimum $2.5 million stockholders' equity requirement, reporting approximately $(81,000) as of June 30, 2025.
-
Compliance Plan Deadline
The company has 45 calendar days, until February 26, 2026, to submit a plan to regain compliance with Nasdaq's listing rules.
-
Expected Resolution
SciSparc anticipates regaining compliance by December 31, 2025, citing proceeds from a $4.2 million debenture conversion in August 2025 and a registered direct offering in November 2025.
auto_awesomeAnalisis
SciSparc Ltd. has received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement, reporting a negative equity balance of approximately $(81,000) as of June 30, 2025, significantly below the $2.5 million threshold. This notice highlights severe financial distress and poses a material risk to the company's Nasdaq listing if not resolved. While the company expects to regain compliance by December 31, 2025, through recent financing activities, investors should closely monitor the situation as failure to meet Nasdaq's requirements could lead to delisting.
En el momento de esta presentación, SPRC cotizaba a 1,45 $ en NASDAQ dentro del sector Life Sciences, con una capitalización de mercado de aproximadamente 4,8 M$. El rango de cotización de 52 semanas fue de 1,25 $ a 19,09 $. Este documento fue evaluado con un sentimiento de mercado negativo y una puntuación de importancia de 8 sobre 10.